Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection

This billing/coding guidance covers MolDx-approved molecular tests for solid organ allograft rejection when the test and clinical use meet the coverage criteria of LCD L38568. Claims must include the appropriate CPT and ICD-10-CM codes, report 1 unit of service, and include the correct DEX Z-Code (different Z-Codes for protocol vs for-cause testing) placed in the specified claim fields; only tests listed on the DEX registry and assessed/compliant with MolDx are covered.

"Molecular testing for solid organ allograft rejection is covered when the specific test and clinical use meet the coverage criteria of LCD L38568."

Sign up to see full coverage criteria, indications, and limitations.